BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
104 results:

  • 1. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
    Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
    J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hairy cell leukaemia with unusual braf mutations.
    Maitre E; Macro M; Troussard X
    J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hairy Cell leukemia: Where Are We in 2023?
    Mendez-Hernandez A; Moturi K; Hanson V; Andritsos LA
    Curr Oncol Rep; 2023 Aug; 25(8):833-840. PubMed ID: 37097545
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]    [Full Text] [Related]  

  • 7. Erdheim-Chester Disease with braf V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
    Prabhakaran N; Jour G; Balar A; Ward N
    Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Oncological management dilemma: a rare presentation of hairy cell leukaemia with hepatic involvement presenting concomitantly with pancreatic adenocarcinoma.
    Al-Saheli ZI; Bazzi T; Barthel B
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414341
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High-grade desmoplastic infantile astrocytoma in a 1-year-old child with Down's syndrome: a case report.
    Habib MH; Alavi MZ; Goraya A; Zaman S; Ahmed A
    J Med Case Rep; 2022 Nov; 16(1):427. PubMed ID: 36333774
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular and oral manifestations of langerhans cell histiocytosis preceding acute myeloid leukemia.
    Zhang Q; Wu X; Wang X; Pan E; Ying L
    BMC Oral Health; 2022 Sep; 22(1):386. PubMed ID: 36064398
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mast cell leukemia with novel braf variant and concomitant atypical KIT variant.
    Chen T; Malysz J; Washburn E; Songdej N; Zhang Y; Bayerl M
    Cancer Genet; 2022 Aug; 266-267():33-36. PubMed ID: 35717863
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CD103-CD23+ classical hair cell leukemia: A case report and review of the literature.
    Zhao HL; Cui HH; Jin LF; Zhao M; Shen WZ
    Medicine (Baltimore); 2021 Dec; 100(51):e28262. PubMed ID: 34941102
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
    Broccoli A; Terragna C; Nanni L; Martello M; Armuzzi S; Agostinelli C; Morigi A; Casadei B; Pellegrini C; Stefoni V; Sabattini E; Argnani L; Zinzani PL
    Hematol Oncol; 2022 Feb; 40(1):57-62. PubMed ID: 34653277
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
    Kreitman RJ; Arons E
    Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?].
    Troussard X; Maitre E; Paillassa J
    Bull Cancer; 2021; 108(7-8):771-778. PubMed ID: 34023063
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibitor of braf
    Smirnova SY; Al-Radi LS; Moiseeva TN; Gemdzhian EG; Yakutik IA; Julhakyan HL; Novikov VA; Galstyan GM; Sudarikov AB
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):427-430. PubMed ID: 33811006
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and braf in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
    Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
    Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A double mutation of braf L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma: A case report.
    Chen L; Wu Y; Bai H; Liu H; Li X
    Medicine (Baltimore); 2021 Feb; 100(6):e24458. PubMed ID: 33578538
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.